Risk of malignancy in a high-incidence population-based cohort of Faroese patients with inflammatory bowel disease from 1960 to 2020: a Faroese IBD cohort study

Jóngerð Midjord, Kári Rubek Nielsen, Amanda Vang, Marin Strøm, Søren N. Lophaven, Turið Hammer, Johan Burisch

Research output: Contribution to journalArticlepeer-review

Abstract

Background: The association between inflammatory bowel disease (IBD) and malignancy remains
disputed despite many observational studies. The Faroese population exhibits the highest occurrence of
IBD in the world. This study aimed to investigate the cancer risk in Faroese IBD patients in a nationwide
IBD cohort.
Methods: This study included all IBD patients diagnosed in the Faroe Islands between 1960 and 2020.
Clinical demographics and cancer diagnoses were retrieved from patient files and the Faroese cancer
registry. Cancer risk in IBD patients was calculated as standardized incidence ratios (SIRs) based on the
Faroese background population’s age- and sex-specific cancer incidence rates, retrievable from NORDCAN.
Results: The cohort consisted of 699 patients with a total follow-up time of 9,629 person-years. Overall,
the risk of cancer was not statistically significantly increased compared to the background population.
Patients diagnosed with cancer at age 50–59 years had higher overall cancer risk (SIR 1.8; 95% CI, 1.02–
2.99) as did UC patients diagnosed with IBD at 50–59 (SIR 2.1; 95% CI, 1.10–3.54). Absolute numbers
were small and no estimates for site-specific cancers reached statistical significance, though lung, breast,
and cancer of the female reproductive organs were elevated among IBD and UC patients, and colorectal
cancer in CD patients.
Conclusions: This nationwide study found no statistically significantly increased risk of cancer among
Faroese patients with CD or UC, except from age 50 to 59 years. While the incidence of IBD is significantly
higher in the Faroe Islands than in other countries, risk estimates of cancers are comparable.
Abbreviations: ANCR: association of the nordic cancer registries; CD: crohn’s disease; CI: confidence
interval; CRC: colorectal cancer; HR: hazard ratio; IBD: inflammatory bowel disease; IBDU: inflammatory
bowel disease unclassified; ICD: international classification of diseases; IQR: interquartile range; IRR:
incidence rate ratio; PY: person-years; RR: rate ratio; SIR: standardized incidence ratios; UC: ulcerative colitis
Original languageEnglish
Pages (from-to)1-8
Number of pages9
JournalScandinavian Journal of Gastroenterology
DOIs
Publication statusPublished - 26 Feb 2024

Keywords

  • inflammatory bowel disease
  • ulcerative colitis
  • crohn's disease
  • malignancy
  • Faroe Islands

Fingerprint

Dive into the research topics of 'Risk of malignancy in a high-incidence population-based cohort of Faroese patients with inflammatory bowel disease from 1960 to 2020: a Faroese IBD cohort study'. Together they form a unique fingerprint.

Cite this